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INTRODUCTION
Full understanding of  the molecular biology of  the hu-
man hepatitis B virus (HBV) is hampered by a variety of  
experimental restrictions. There is no small animal model 
system available for infection studies and only few aspects 
of  the viral life cycle are accessible to biochemical meth-
ods. A complete viral infection cycle mimicking natural 
HBV infection in vitro could only be achieved until recently 
with primary human hepatocytes. The disadvantages of  
this system are: (1) restricted accessibility to the cells, (2) 
infection inefficiency and (3) high variability in infection 
assays. The recent establishment of  the HepaRG cell line 
is therefore a major breakthrough and allows HBV infec-
tion studies under defined conditions for the first time[1].
This review will focus on one of  two established animal 
virus models; i.e., the DHBV model system. The human 
HBV and DHBV share several fundamental features. Both 
viruses have a partially double-stranded DNA genome that 
is replicated via an RNA intermediate and the coding open 
reading frames (ORFs) overlap extensively. In addition, the 
genomic and structural organization, as well as replication 
and biological characteristics, are very similar in both 
viruses. They both infect hepatocytes preferentially and 
have a very similar life cycle. Most of  the key features of  
hepadnaviral infection were first discovered in the DHBV 
model system and subsequently confirmed for HBV. 
This includes replication of  the viral genome by reverse 
transcription of  a RNA intermediate[2], mechanisms of  
covalently closed circular (ccc) DNA formation and 
amplification[3], details of  reverse transcription[4], and 
determinants of  host tropism[5].
In light of  the above mentioned austerities for HBV, 
the DHBV model of  hepatitis B virus infection remains a 
convenient and reliable system that offers several unique 
advantages. Most importantly, steady availability and 
highly reproducible infection of  primary duck hepatocytes 
(PDHs) provide the optimal basis for in vitro and in vivo 
studies of  the molecular and cellular biology of  hepatitis 
B virus infection under defined and controlled conditions. 
In addition, the chicken hepatoma cell line LMH produces 
progeny virus after transfection with cloned, mutant or wt 
DHBV genomes, which can be used to infect PDHs or 
ducks[6].
Thus, the DHBV model system is a unique system 
that allows elucidation of  the hepadnaviral life cycle in 
considerable detail. However, there are several differences 
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Abstract
The human hepatitis B virus (HBV) and the duck hepa-
titis B virus (DHBV) share several fundamental features. 
Both viruses have a partially double-stranded DNA ge-
nome that is replicated via a RNA intermediate and the 
coding open reading frames (ORFs) overlap extensively. 
In addition, the genomic and structural organization, 
as well as replication and biological characteristics, are 
very similar in both viruses. Most of the key features of 
hepadnaviral infection were first discovered in the DHBV 
model system and subsequently confirmed for HBV. 
There are, however, several differences between human 
HBV and DHBV. This review will focus on the molecular 
and cellular biology, evolution, and host adaptation of 
the avian hepatitis B viruses with particular emphasis on 
DHBV as a model system.
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between human HBV and DHBV. First of  all, DHBV 
infection normally results in chronicity since the virus is 
transmitted from the hen to the egg (see[7] and references 
therein). This infection usually does not lead to liver injury 
and the infected duck remains healthy throughout life. 
When an adult duck is infected, the infection is usually 
eliminated. When HBV is transmitted from mother to 
child, it also often results in chronic infection. However, 
in a large number of  cases, this leads to liver injury and 
development of  hepatocellular carcinoma or cirrhosis. 
When an adult is infected, this can either result in 
fulminant, acute or chronic hepatitis when the virus is not 
eliminated. Another difference between DHBV and HBV 
is expression of  the X protein (for further differences see 
Table 1). This regulatory protein, with not fully understood 
function, is expressed by HBV from a conventional ORF, 
but in DHBV, an unusual cryptic ORF is used.
In the last two decades, parts of  the hepadnaviral 
life cycle, especially the replication strategy, could be 
undeceived in considerable detail. In contrast, there is 
very little information available on the infectious entry 
or secretion pathway. The cellular partners involved in 
cell-virus interactions at these stages of  infection remain 
unidentified and the molecular determinants of  host 
specificity, hepatotropism and the nature of  the receptor 
complex still await discovery.
For more information about human HBV and the 
other corresponding model systems please see the compre-
hensive reviews in this issue.
AVIAN HEPATITIS B VIRUSES
The duck hepatitis B virus was discovered in 1980 by 
William Mason and colleagues[8]. They found a virus very 
similar to HBV in about 10% of  Pekin ducks from two 
different sources in the USA and they pointed out that 
no abnormal level of  mortality or signs of  hepatitis were 
found in the infected ducks. Naturally occurring DHBV 
infections have been reported in Pekin ducks and related 
species from China, USA, Canada, Europe, India, and 
South Africa[9-11].
Since then, avihepadnaviruses have been detected in 
various duck species[10] including exotic ducks and geese[10] 
(DHBV), in snow geese[12] (SGHBV), a Ross’ goose 
(RGHBV, GenBank Acc.No. M95589), white storks[13] 
(STHBV), demoiselle and grey crowned cranes[14] (CHBV) 
as well as grey herons[15] (HHBV). Like their mammalian 
counterparts, avihepadnaviruses have a rather narrow 
host range. For instance, DHBV infects only certain duck 
and goose species but neither infects Muscovy ducks nor 
chickens[16]. Little is known about the host range of  HHBV 
or STHBV. Despite its substantial sequence homology 
with DHBV, HHBV does not infect ducks and only very 
inefficiently primary duck hepatocytes[15]. Recently, we 
reported that cranes are naturally infected with a hepatitis 
B virus, designated CHBV[14]. Cranes are phylogenetically 
very distant from ducks and are more closely related to 
herons and storks (Figure 1). Interestingly however, CHBV 
infects primary duck hepatocytes with similar efficiency as 
DHBV. Collectively this and related data suggest that the 
host range of  hepadnaviruses cannot be simply predicted 
based on the evolutionary relatedness of  their respective 
hosts. For a comprehensive sequence comparison and a 
phylogenetic tree of  the host birds see[14].
Phy logenet ic ana lys i s of  the var ious i so la tes 
demonstrated a rather high variability among DHBV 
strains, whereas genomes from other avihepadnaviruses, 
such as stork or crane hepatitis B virus, appear less 
variable. HHBV infection occurs not only in captive grey 
herons, but also with high prevalence in free-living birds. 
We have detected HHBV in another heron species (great 
blue heron) as well as in two of  its sub-species (great white 
heron and Würdemann’s heron). Thus, the virus persists 
in free-living birds and is an endogenous virus of  several 
heron species.
DHBV will certainly remain the most important 
avihepadnavirus for research purposes since the infection 
system with PDHs and the important research tools 
are well established. It is possible to generate mutant 
viruses after transfection of  cloned DHBV genomes into 
the chicken hepatoma cell line LMH[6]. Thus, different 
mutations can be studied not only concerning their effects 
Figure 1  Phylogenetic tree of avian hepadnaviruses and related hosts. 
Phylogenetic relationship of all known avian hepadnaviruses based on preS/S 
gene sequence. The corresponding natural hosts are also indicated.
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Table 1  Comparison of HBV and DHBV
HBV DHBV
Natural host Human Pekin duck
Related viruses WM-HBV, WHV HHBV, SGHBV
Pathogenicity
Chronic infection yes yes
Liver injury yes no
Experimental systems
Cell transfection yes yes
In vitro infection yes yes
Transgenic mouse yes no
Small animal model no yes
WMHBV: woolly monkey HBV; WHV: woodchuck HBV; HHBV: heron HBV; 
SGHBV: snow goose HBV.
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on replication but also on infection efficiency and events. 
In addition, in vivo infections can be performed in ducks 
without the need to establish expensive handling facilities 
and without risk. In these ducks not only the host range 
of  hepadnaviruses can be studied in considerable detail (in 
addition to in vitro studies), but also the activity and toxicity 
of  antiviral substances can be addressed[17].
THE AVIHEPADNAVIRAL LIFE CYCLE: AN 
OVERVIEW
Avian hepatitis B viruses belong to the family of  DNA 
viruses that replicate their DNA genome by reverse 
transcription of  an RNA intermediate. Thus, they belong, 
together with the cauliflower mosaic virus, to the group of  
pararetroviruses that do not integrate their genome into 
host cell chromosomes.
A schematic view of  the DHBV genome and structure 
of  virions is shown in Figure 2. The genome of  DHBV 
has an unusual design. It consists of  a ca. 3000 bp partially 
double-stranded DNA. The circularity of  the genome is 
achieved by overlapping cohesive 5’ ends[18]. The coding 
negative strand is complete and even has a short terminal 
redundancy but is not covalently closed. Its 5’ end is 
covalently attached to the viral polymerase P[19]. The 
positive strand is not complete but encompasses between 
40% and 85% of  the genome[20]. However, the length 
of  the gap varies among different hepadnaviruses and is 
smallest in DHBV[18]. Attached at the 5’ end of  the positive 
strand is a short ribooligonucleotide, which is a remnant 
of  the pregenomic RNA (pgRNA)[21]. Both 5’ terminal 
structures function as primers during viral replication[21]. 
As another particularity, the viral genome has two direct 
repeats (DR) with a length of  11 base pairs that have 
important functions in replication.
The viral genome organization is very compact and 
economic. All nucleotides have a coding function in 
at least one of  the four open reading frames (ORFs). 
Regulatory sequences such as enhancers and promoters, 
as well as several cis-acting elements, overlap with coding 
regions. The first ORF encodes the surface proteins L and 
S, the second codes for the capsid protein as well as the 
e-antigen, the third for the polymerase and a cryptic fourth 
for the X protein[22].
Two different types of  spherical viral particles can be 
detected in the serum of  infected ducks: infectious virus 
particles (virions) with a diameter between 40 and 60 nm 
and subviral particles (SVPs) with a diameter between 30 
and 60 nm, which lack the 27 nm nucleocapsid, including 
the viral genome[23]. After transfection of  cell lines, a 
third particle entity can be detected in the cell culture 
supernatant. These cells secrete so called ‘naked capsids’ 
lacking the viral envelope for unknown reasons.
The virus is surrounded by a lipid envelope, which 
presumably originates from the host cell endoplasmic 
reticulum (ER) membrane, and contains both viral surface 
proteins. For HBV, it has been shown that the membrane 
is rich in phosphatidyl choline (60% of  all lipids) as well 
as cholesterol (30% of  all lipids)[24] and thus differs from 
the lipid composition of  the cellular ER membrane, 
implicating that lipids are actively selected for the viral 
membrane. In total, the amount of  lipids in comparison 
to the amount of  protein is very small, in SVPs the weight 
ratio is about 1:4[25]. Thus, the lipids in the viral envelope 
are presumably not forming a lipid bilayer but protein 
aggregates seem to be separated through short lipid 
regions[26]. This strongly restricts the lateral mobility of  
the envelope components. The lipid composition of  the 
DHBV envelope remains to be determined.
SVPs largely consist of  the viral surface proteins S 
and L, which are incorporated into the envelope. They do 
not contain viral DNA and are thus not infectious. This 
entity is secreted from infected cells in excess compared to 
virions. It is assumed that per virion 1000 to 10 000 SVPs 
are secreted[27]. SVPs can compete with viral binding and 
thus infection[28]. In contrast, it has been shown that SVPs 
enhance infection when a very low multiplicity of  infection 
(MOI) is used, which indicates an important role in the 
viral life cycle[29].
Complete virions contain an icosahedral capsid inside 
the envelope, which is about 35 nm in diameter as seen 
in cryo-electron microscopy or 27 nm in negative stain 
pictures and consists of  240 subunits of  core protein[30]. 
The nucleocapsid holds the viral DNA genome with the 
covalently attached polymerase.
Cellular components can additionally be packed into 
viral particles. This is the case for Hsc70, which was 
detected in large amounts[31]. The identity and function of  
other proteins of  cellular origin are still unknown.
A schematic view of  the viral life cycle is shown in 
Figure 3. The life cycle of  DHBV starts with attachment 
of  the viral particles to their receptor/receptor complex 
on the surface of  the target host cell. This is mediated 
by the preS domain of  the viral L protein that binds to 
Figure 2  Virion structure and genome organization of avian hepadnaviruses. 
The viral envelope is derived from hepatocellular membranes and contains the 
viral surface proteins S and L. It covers the nucleocapsid harbouring the viral 
genome with the covalently linked terminal protein domain (TP, orange circle) 
of the polymerase (P, red circle) and cellular proteins like Hsc70. The genome 
is organized as depicted. The various transcripts are indicated by thin lines with 
the small arrowhead indicating the start sites. The partially double stranded, viral 
DNA with the covalently bound TP domain of P (red circle) is symbolized by the 
thicker lines. The numbered circles 1 and 2 on the viral DNA represent the direct 
repeats (DR). Enh represents the enhancer domain. The ORFs encoding core (C), 
polymerase (P), and the surface proteins (preS and S) are symbolized by thick 
arrows. Epsilon (Dε) is the stem loop structure on the pgRNA which acts as an 
encapsidation signal and replication origin. The second encapsidation element DεII 
is unique to avian hepatitis B viruses, since the mammalian counterparts lack this 
RNA structure. SD and SA represent the major splice donor and acceptor sites, 
respectively.
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unknown cellular receptor compounds. After binding, viral 
particles are taken up into the cell by receptor-mediated 
endocytosis [32-34]. Then, the nucleocapsid is released 
from the endosomal compartment into the cytosol. It is 
currently under discussion whether a low endosomal pH is 
necessary for this release. The cytoplasmic nucleocapsids 
are then transported to the nucleus to initiate productive 
infection. This transport strongly depends on active 
microtubules (MT) but not on actin[27].
After reaching the nuclear membrane, the core protein 
is presumably phosphorylated and exposes a nuclear 
localization signal. This results in binding of  nuclear 
factors; e.g., importins, to the capsid, which leads to uptake 
of  the whole complex into the nucleus [35]. However, 
disassembly of  the capsid near the nuclear membrane and 
subsequent transport of  the viral DNA into the nucleus 
cannot be excluded.
In the nucleus, the relaxed form of  the viral genome, 
the rcDNA (relaxed circular), is converted into the 
covalently closed, circular form (cccDNA). This is only 
possible after removal of  the 5’-terminal structures (protein 
and RNA), repair of  the gap and covalent ligation of  the 
strands by cellular proteins. The cccDNA is usually not 
incorporated into the host genome but is organized in 
nucleosomes in the form of  an episome[36].
Transcription of  the viral genome is mediated by the 
cellular RNA polymerase Ⅱ[37]. In vivo, three different 
viral RNA classes could be identified, which are all 
polyadenylated and posses a cap structure[21]. They all 
have the same 3’ end since only one polyadenylation site is 
present in the viral genome but have different 5’ ends due 
to different transcription initiation sites. The different viral 
Figure 3  Model of the hepadnaviral life cycle. The hepadnaviral particle binds the hepatocyte via a specific receptor complex/molecule. It then enters the cell via 
endocytosis and is transported intracellularly in a MT-dependent fashion. After release out of the endosomal compartment, the nucleocapsid containing the viral DNA binds 
the nuclear pore complex and the viral genome is released into the nucleus. It is also possible that the whole nucleocapsid enters the nucleus and releases the viral DNA 
inside. Afterwards, the viral rcDNA is converted into cccDNA and viral transcripts are made. These are exported into the cytosol where the pgRNA is packaged together with 
the viral polymerase into the nucleocapsid. Inside the capsid, the RNA is reverse transcribed into the viral DNA genome. These matured nucleocapsids can then either be 
transported to the nucleus to add to the cellular cccDNA pool or they interact with viral surface proteins on the cellular ER membrane. There, the nucleocapsid buds into the 
lumen of the ER and is then transported in a yet undefined fashion to the cell surface where the viral particle is released into the cell exterior.
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RNAs are transported into the cytoplasm and translated. 
The two longest RNAs (3.5 kb), which stretch the whole 
genome, have two different functions. They code for the 
viral proteins core, the polymerase and e-antigen but one 
also serves as the pregenome[21]. Part of  the 3.5 kb mRNA 
is spliced and serves as mRNA for L protein synthesis. A 
second class of  viral RNAs (2.1 kb) encodes for the large 
surface protein, and the third class (1.8 kb) codes for the 
small surface protein, which is the most abundant one. 
The identity of  the X-encoding RNA is unknown.
After export into the cytosol, the viral RNAs are 
translated and the viral surface proteins are directly 
inserted into the ER membrane. Once inserted, they can 
autonomously form subviral particles or interact with 
capsids to form virions.
In the cytosol, core protein dimers interact with each 
other and self  assemble with the viral polymerase and the 
pgRNA into ribonucleoprotein complexes[38]. The pgRNA 
is packaged upon a chaperone-mediated interaction of  
the polymerase with the stem loop structure epsilon (ε). 
This structure also serves as the replication origin for the 
reverse transcription. Prior to packaging, the core protein 
is phosphorylated[39]. It is currently unclear whether reverse 
transcription initiates during ribonucleoprotein complex 
formation or after assembly of  the capsid. However, 
when the pgRNA is inside the capsid, the particles mature, 
e.g. the RNA is reverse transcribed into the viral DNA 
genome and the core proteins are dephosphorylated[2,40]. 
The mature capsids interact with the viral surface proteins 
at the membrane of  the ER and bud into the lumen, 
thus forming complete virions. The enveloped virions 
are then presumably transported through the constitutive 
secretion pathway to the cell surface and are released there. 
Alternatively, mature capsids can be transported to the 
nucleus and add to the cccDNA pool. After a successful 
infection, between one and 20 cccDNA molecules can 
be detected inside the nucleus[41]. This re-infection cycle 
preferentially occurs during establishment of  an infection 
when the levels of  large surface protein are low[42]. After a 
successful infection, the levels of  L inside the cell rise and 
capsids preferentially form virions and are secreted.
In the absence of  mature capsids and due to the 
autonomous budding activity of  the viral surface proteins, 
subviral particles are formed. S as well as L proteins seem 
to accumulate in membrane domains of  the ER where 
they reach quite high densities. When they reach a critical 
density, they presumably bud into the ER lumen and form 
subviral particles.
DHBV PROTEINS AND THEIR BASIC 
FUNCTIONS IN VIRAL ENTRY, 
REPLICATION, AND MORPHOGENESIS
Core protein and e-antigen
The viral core protein fulfils several opposing functions 
during the different stages of  the viral life cycle; e.g., nu-
cleic acid binding and assembly opposed to disassembly 
and nucleic acid release. These diverse functions are partly 
regulated by: (1) subcellular localization, (2) quaternary 
structure and (3) posttranslational modification by phos-
phorylation and dephosphorylation of  its C-terminus.
The viral nucleocapsid is composed of  dimeric 
subunits of  the viral core protein (DHBc) with a molecular 
weight of  32 kDa. The N-terminal region of  the core 
protein (up to about 144 aa) is acetylated[43] and sufficient 
for assembly of  the capsid shell[44,45]. The carboxyterminal 
end of  the protein, the so called C-terminal domain (CTD), 
is extremely basic and binds nucleic acids. This is essential 
for packaging of  the pgRNA into the nucleocapsid as 
well as progression of  reverse transcription within[44,46]. In 
addition, a nuclear localization signal is present between aa 
184 and 226 along with a nuclear export signal[47].
The major phosphorylation sites in the core protein 
are mapped to the arginine-rich C-terminus. This domain 
contains consensus sequences for different cellular 
kinases, such as PKC, SRPK1 and SRPK2 (Figure 4). 
Furthermore, Thr174 is highly conserved and is a cdc2 
kinase phosphorylation site. Compared to the extracellular 
core protein, intracellular core is highly phosphorylated. 
Mutational analysis of  the major phosphorylation sites 
revealed that individual or combined substitution had no 
overt effect on pgRNA packaging. However, the S245A 
mutant was deficient in genome maturation[48]. It has 
been shown that the CTD contains several phosphosites, 
which are heterogeneously phosphorylated intracellularly 
and hypophosphorylated or non-phosphorylated in the 
secreted virion[40,43]. This dephosphorylation, which occurs 
as nucleocapsids mature (meaning that the pgRNA is 
reverse transcribed into the rcDNA genome), is thought 
to be a maturation signal that results in secretion of  only 
fully matured virions containing the DNA genome[43]. In 
addition, it has been shown that binding of  hepadnaviral 
capsids to the nuclear pore complex depends on the 
phosphorylation status of  the core protein[35]. The kinases 
or phosphatases implicated in these steps are not known. 
This is also true for the fate of  the nucleocapsids after 
nuclear binding; it is not known whether they disassemble 
at the nuclear pore and thereafter release the viral DNA or 
if  they are transported through the nuclear pore and then 
disassemble.
DHBc has the autonomous abil ity to assemble 
into particulate structures, which is dependent on the 
DHBc concentration[49]. The nucleocapsid is a dynamic 
structure and subject to regulated conformational 
transitions. Formation of  progeny virions requires stable 
C-terminal sequence of DHBc:
C-terminal sequence of HBc:
indicate consensus sequences for cellular kinases
[
[
…GRRRSKSRERRAPTPQRAGSPLPSSSSHHRSPSPRK
[
[
[
[
[
[
[
[
239 245 257 259
…RRGR SPRRR TP SPRRR RSQ SPRRR RSQSRESQC
155 162 170
Figure 4  Phosphorylation sites of the viral core protein. The C-terminal sequence 
of the core proteins from DHBV and HBV are shown. Red brackets indicate 
the phosphorylation motifs, bold letters indicate the phosphorylated amino acid 
residue.
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nucleocapsids, whereas during viral entry, the incoming 
viral structure must disassemble and release the viral 
genome. Furthermore, reverse transcription of  the viral 
genome occurs within the capsid and it is thought that this 
is linked with structural rearrangements in the capsid.
The ultrastructural analysis of  the HBV core protein 
revealed that the monomeric form is dominated by a 
long alpha-helical hairpin structure[45]. The first step of  
capsid formation is the homodimerization of  two core 
protein monomers that arrange in a way that leads to an 
antiparallel order, which results in an almost exact twofold 
symmetry. As a result, the characteristic spike on the capsid 
surface is formed by a compact four helix bundle. These 
spikes are the regions that interact in the virion with the 
viral envelope structures. Preliminary 3D reconstruction 
of  the DHBV capsid suggests that the protein forms 
T-shaped dimers similar to the human core protein (M. 
Nassal, personal communication).
The open reading frame that encodes DHBc also 
codes for a nonstructural viral protein, which is the 
DHBe or precore. This e-antigen is, compared to the 
DHBc, truncated at the C-terminus and extended on 
the N-terminus. In addition it contains a type I signal 
recognition sequence. It is translocated into the ER during 
synthesis where the signal recognition sequence is cleaved 
and the C-terminus removed. After this processing, 
e-antigen is transported through the Golgi complex and 
secreted from the infected cell[50,51]. It has been shown that 
the e-antigen is glycosylated[50]. The glycosylation pattern 
seems to differ among the different avian hepadnaviruses 
and even among different isolates of  DHBV due to the 
presence of  different numbers of  N-glycosylation sites. 
This is, for instance, obvious in a recent study of  HHBV 
e-antigen that has one glycosylation site. This resulted in 
two bands in immunoblot analysis (one for glycosylated 
and for non-glycosylated e-antigen), while CHBV e-antigen 
with two N-glycosylation sites showed three bands on the 
immunoblot[14].
DHBe can be detected in the serum of  infected 
ducks[52] and serves as a marker for efficient viral repli-
cation. Its exact function is unknown, but it has been 
shown that it plays no essential role in viral replication, 
morphogenesis or infectivity[53]. However, it seems to play 
a role in the establishment of  chronic infections[54] and its 
absence may confer a growth advantage of  precore-minus 
mutants over wildtype virus[55].
Polymerase
The viral polymerase is a multifunctional protein of  about 
90 kDa in size. It has a DNA-dependent DNA polymerase 
activity/domain to fill the gap in the viral DNA during 
repl icat ion[56] and an RNaseH activity/domain to 
selectively digest RNA from an RNA-DNA-hybrid 
molecule[57], as it has been shown for HBV. It also has 
reverse transcriptase (RT) activity to transcribe the RNA 
pregenome into the DNA genome during replication[2]. 
The polymerase homology domain is centrally located, 
whereas the RNaseH homology domain is located near the 
C-terminus of  the protein. Viruses with point mutations in 
these regions are either defective for viral DNA synthesis 
or only allow negative-strand but not positive-strand DNA 
synthesis [56]. Most N-terminal sections of  the polymerase 
domain are spacer regions without any other apparent 
function[58]. Most N-terminal sections are the region 
implicated in the covalent linkage of  the P protein to the 
viral DNA often referred to as terminal protein.
In the process of  viral genome replication, during 
which the pregenomic RNA is transcribed into the 
genomic DNA, the different domains can assert their 
different functions. The pgRNA is transcribed from the 
viral cccDNA by cellular polymerase Ⅱ. This RNA is then 
transported into the cytosol and binds the viral polymerase 
and the core proteins. The polymerase recognizes the 
epsilon and another downstream region on the viral 
RNA and binds there with the help of  cellular proteins 
like Hsp90[59]. Inside the particle, the RNA is transcribed 
into the negative strand DNA by the RT domain of  the 
polymerase. This process is primed by the protein itself  
and tyrosine 96 of  the P protein serves as a primer[60]. This 
results in covalent attachment of  the nascent DNA strand 
onto the terminal protein part of  the polymerase. After 
attachment of  about 4 nucleotides, this DNA product is 
transferred to the DR1 sequence on the viral pgRNA. This 
is possible since the epsilon signal and the DR1 share a 4 
nucleotide identity. From this position, the DNA negative 
strand is elongated by the conventional mechanism[61,62]. As 
this elongation proceeds, the template RNA is degraded 
by the RNaseH activity of  the viral polymerase[2,63]. The 
end product of  this reaction is a negative-stranded DNA, 
which is terminally redundant by about 8 nucleotides.
Positive strand synthesis is initiated at DR2 and 
primed by a short oligoribonucleotide, which is a remnant 
from the pgRNA[64]. This primer is transferred to a 
complementary region at the 5’ end of  the negative strand 
DNA for positive strand synthesis. From there, synthesis 
of  the positive strand proceeds.
Sometimes (in about 1% to 5% of  cases) the primer 
fails to translocate. This results in a process called in situ 
priming, where a fully duplex linear DNA is the end 
product[65]. This is a dead end for viral replication but may 
be the cause for integration of  some viral genomes into 
the chromosomal DNA of  the host cell.
Elongation of  the positive strand proceeds until 
the 5’ end of  the negative strand is reached. Then, an 
intramolecular strand transfer is needed to complete 
positive strand synthesis. This happens after circularization 
of  the genome, which is possible because of  the short 
redundancies at each strand end. After the circularization, 
positive strand synthesis can proceed. Usually elongation 
does not proceed until the end of  the template is reached. 
In the case of  DHBV, normally about 80% of  the positive 
strands complete elongation[20].
Envelope proteins
The multiple functions of  the viral envelope proteins 
are reflected by the domain organization and unique 
biochemical features. The DHBV envelope proteins are 
encoded by a single ORF consisting of  the preS and S 
domain. The viral envelope proteins are inserted into the 
membrane of  the virus that originated from intracellular 
membranes (presumably the ER) of  the infected cell. In 
the case of  DHBV, these envelope proteins are the small 
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protein S, which constitutes about 80% of  total envelope 
proteins, and the large protein L, which constitutes about 
20%[66,67]. S protein is thus the most abundant protein in 
the viral envelope. It determines the envelope curvature 
and is indispensable for both budding and secretion of  
viral particles. Both viral surface proteins are unique 
compared to other viral surface proteins in their relatively 
complex structure and topology[68]. They have a molecular 
weight of  18 and 36 kDa, respectively, and are anchored 
in the membrane by several transmembrane domains. 
The C-terminus of  both proteins are identical, while L 
is N-terminally extended by 161 aa compared to S. The 
length of  this extension varies with the isolate. This 
unusual organisation results from differential transcription 
of  a single ORF[67] (Figure 2).
The L protein is modified with myristic acid at its 
N-terminal glycine after removal of  the first amino acid 
methionine, which presumably anchors the protein in the 
membrane in addition to the transmembrane domains[69]. 
This myristoylation is required for infectivity of  the virus 
but not for assembly[69]. Unlike the envelope protein of  
HBV, DHBV L and S are not modified by N-glycosylation 
although they contain consensus glycosylation sites. In 
contrast, it has been shown that the DHBV L protein (p36) 
is the only surface protein that is phosphorylated[70,71]. This 
phosphorylation occurs at serine 118 by an ERK-type 
MAP kinase and is not essential for viral replication, parti-
cle formation or infectivity[71].
As transmembrane proteins, L and S are incorporated 
cotranslationally into the ER membrane. The proteins have 
four transmembrane domains (TM1 to TM4) that anchor 
them in the membrane and consist of  membrane-spanning 
hydrophobic alpha-helices (Figure 5). In addition, the preS 
domain of  the L protein contains two translocation motifs 
(TLM), which are 12 amino acid encompassing domains 
that form an amphipathic alpha helix[32]. TLMs mediate 
an energy- and receptor-independent transfer of  peptides, 
nucleic acids and proteins when fused to them across 
membranes without affecting their integrity[72]. The DHBV-
TLMs are located between amino acids 20-31 (TLM1) and 
42-53 (TLM2) and required for viral infectivity.
Worth mentioning is the dual topology of  the L 
protein[73]. After cotranslational insertion of  the protein 
into the cellular membrane, part of  the proteins changes 
the topology (Figure 5). This leads to exposure of  the 
N-terminus to the cytosolic side of  the membrane in 
about half  of  the L proteins while the other half  has the 
N-terminus directed to the luminal side[74]. In this way, the 
protein can fulfil two different functions: it can interact 
with the cellular receptor on the outside of  the virus and it 
can interact with the nucleocapsid on the inside. Whether 
S also adopts a dual topology remains to be determined.
The viral surface proteins are able to autonomously 
form subviral particles without the help of  an interacting 
nucleocapsid. The exact mechanism of  this phenomenon 
is not known, yet it is assumed that the proteins interact 
with each other to form microdomains in the ER 
membrane from which they bud when they reach a critical 
density. A prerequisite for this budding activity would be 
a tight interaction of  the viral surface proteins with the 
membrane lipids and a membrane bending activity. When 
L protein is expressed without the S component, particles 
are formed inside the cells, but are not secreted. This 
retention and secretion defect can be overcome by co-
expression of  the S protein[75]. This implies an important 
function for the S protein in secretion of  viral particles.
Another function of  the L protein is regulation of  
cccDNA amplification. As mentioned above, cccDNA 
is the replication template for all hepadnaviruses. It 
is a prerequisite for maintaining chronic infection of  
hepatocytes and is the main obstruction during antiviral 
therapy since it is mostly not eliminated from the cells. The 
amount of  cccDNA inside the host cell nucleus is thus of  
great importance for the virus. To maintain its replication 
template in the nucleus, it re-infects and this process is 
regulated in an elaborate manner by the large viral surface 
protein[76]. During the early stage of  infection when the 
amount of  L protein is low inside the cell, mature core 
particles preferentially infect the nucleus to add to the 
cccDNA pool. Concomitant with the increase in cccDNA, 
the levels of  L increase. This leads to redirection of  the 
mature capsids into the secretory pathway and reduces 
cccDNA amplification.
The L protein is also responsible for superinfection 
exclusion, which prevents hepadnaviral infection of  
already infected hepatocytes[77]. This phenomenon was 
first ascribed to downregulation of  the putative viral 
receptor protein gp180. This has not been confirmed 
and it has been suggested that superinfection exclusion 
may result from a role of  L as a regulator of  intracellular 
trafficking[77].
The L protein not only plays a role in viral morpho-
genesis or cccDNA amplification, but it is also implicated 
in additional regulatory functions such as signalling[71]. 
The cytosolically exposed preS domain of  the L protein 
has the potential to activate gene expression from cellular 
promoter elements in trans. It is also phosphorylated by 
ERK2 at serine 118, which is induced by various stimuli 
and may play a role in intracellular virus-host crosstalk[71].
X protein
One major difference between the avian and mammalian 
hepatitis B viruses is the presence of  an ORF called X in 
the latter. The function of  this regulatory protein is still 
far from being understood. Recently it has been reported 
Figure 5  Dual topology of the viral surface protein L. The L protein is inserted into 
the ER membrane during synthesis with transmembrane domain 2 being inserted 
into the membrane. Half of the proteins then change their topology and insert the 
transmembrane domain 1 into the ER membrane. After this change and formation 
of the virus, L can exert its two basic functions; interaction with the nucleocapsid 
on the cytosolic preS domain and interaction with the host cell receptor on the 
surface of the viral particle.
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that X protein enhances the replication of  transfected 
HBV genomes[78]. DHBV lacks an apparent X-ORF. But 
a cryptic X-like ORF has recently been reported[22]. In vivo 
experiments have suggested no functional role for this 
gene product in DHBV short term infection[79].
DHBV INFECTION
In vitro infection
Hepadnaviruses can only efficiently infect primary 
hepatocytes with the exception of  the recently published 
HepaRG cell line, which can be infected with the human 
HBV[1]. Thus, primary hepatocyte cultures have to be 
established for use with hepadnaviruses. In the case of  
DHBV, either primary fetal or adult hepatocytes can be 
used. Fetal hepatocytes can be obtained easily from the 
livers of  non-hatched duck embryos. These are digested 
with collagenase, washed and plated. This results in a 
mixed culture containing hepatocytes as well as other cells 
of  the liver, which are the non-parenchymal cells, such as 
macrophages, sinusoidal endothelial cells, and fibroblasts. 
Alternatively, primary duck hepatocyte cultures can be 
obtained from adult ducks by liver perfusion. This results 
in a rather homogenous suspension of  cells containing 
high amounts of  hepatocytes (up to 90%) compared to 
non-parenchymal cells. Compared to primary human 
hepatocytes, PDHs are about 20 times more permissive to 
hepadnaviral infection.
The cells are cultured in a standard medium containing 
hydrocortisone, insulin as well as DMSO. The DMSO 
is important for maintaining differentiation and thus 
infectability of  the cells[80]. Under these culture conditions, 
the cells remain infectable for up to 2 weeks in culture and 
viral spread occurs. The DMSO as well as omitting serum 
from the cell culture medium are essential conditions for 
maintaining cellular infectability since addition of  serum 
to the cultures decreases the amount of  cellular receptor 
proteins on the cell surface[81].
Research with the in vitro model of  DHBV infection 
has lead to the discovery of  many different features of  the 
hepadnaviral life cycle. However, while factors involved in 
the early and most vulnerable steps of  the viral life cycle 
(Figure 6) have been identified for a variety of  viruses, 
little is known for hepadnaviruses (for a review see[7] and 
references therein).
Hepatoma cell lines, which can replicate the viral 
DNA and produce progeny virus after transfection of  
the viral genome into the nucleus, are not permissive for 
infection with the virus itself[82]. This phenomenon led 
to the assumption that the absence of  a viral receptor or 
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Figure 6  Current model for entry and intracellular trafficking of DHBV. The hepadnaviral life cycle starts with the attachment of virions to specific binding sites on the 
surface of hepatocytes mediated by the preS region of the large viral envelope protein L. Afterwards the virus enters the cell via endocytosis and resides in an endocytic 
vesicle which is transported in a MT-dependent and probably polar fashion. The endosomal release of the incoming particle requires the activity of the vacuolar H+-ATPase 
and presumably the cholesterol of the viral envelope. After release, the particle is transported in a MT-dependent fashion mediated by dynein/dynactin to the nucleus and 
initiates infection after release of the viral genome at the nuclear membrane or within the nucleus. However, the majority of viral particles is missorted and degraded by the 
proteasome and other cellular proteases.
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receptor complex on the cell surface of  these cells is the 
major determinant for infection. Great effort was invested 
to identify these molecules. But to date, the molecules 
responsible for the viral uptake that leads to productive 
infection are still unknown, although carboxypeptidase D 
(gp180) has been shown to specifically interact with the 
viral L protein and leads to internalization of  viral particles 
after heterologous expression[83-85]. However, this did not 
lead to productive infection of  these cells. In addition, the 
protein has been shown to not only bind DHBV, but also 
the viral surface protein from heron HBV, which does not 
infect PDHs, and this protein is not liver specific. It thus 
cannot be the determinant for viral host range or tissue 
specificity. This shows that either additional factors are 
required for the infection or that gp180 plays no role in 
the productive uptake and binding of  the virus.
Initial binding of  hepadnaviral particles seems to 
involve a component with low affinity without saturation 
and a component with high affinity and saturation[28]. 
This indicates that the binding involves at least two 
determinants and thus components. Several competition 
experiments with recombinant preS peptides, neutralizing 
antibodies and SVPs showed that the preS region of  
the viral L protein is essential for viral binding and the 
establishment of  an infection[26,28,86,87]. In addition, it has 
been shown that preS peptides that were myristoylated 
were much more efficient in preventing DHBV infection 
than non-myristoylated peptides, which indicates that 
the myristoylation of  L plays an important role during 
infection[86].
To gain more insight into the enigmatical early steps 
of  hepadnaviral infection, we recently characterized the 
early attachment and entry events of  DHBV infection in 
PDHs[27]. To do so, we established a sensitive, PCR-based 
assay that allowed us to investigate viral binding and entry. 
This binding and entry assay showed that only a small 
proportion of  the inoculum binds to the cell surface of  
hepatocytes. Also the overall number of  particles that bind 
to the cell surface is quiet low, after 2 h at 4℃, only up to 
10 virions and 10 000 SVPs per cell were detectable. This 
indicates that the number of  hepatocellular surface binding 
sites is about 10 000 per cell. Binding was prevented by the 
use of  neutralizing antibodies as well as suramin, which 
also prevented viral infection showing that the detected 
binding sites are relevant for productive infection.
The steps after viral binding also remain quite elusive. 
It was shown years ago that the kinetics of  DHBV 
uptake is unusual since binding and entry seem to be very 
slow. For a maximal infection efficiency, cells have to be 
incubated with the virus up to 16 h[80]. We have recently 
shown that viral uptake indeed needs an unusually long 
time period[27]. 1 h after attachment only about 70% of  
bound DHBV was taken up and internalization was 
complete within 3 h. This shows that virus uptake itself  
takes a relatively long time period, but since after 3 h all 
bound virions were internalized, uptake is very efficient. 
In contrast, viral trafficking inside the cell does not seem 
to be efficient since a high proportion of  viral particles 
are degraded after viral entry into the cell and thus cannot 
establish infection[34].
It has been shown previously that DHBV entry into 
PDHs requires energy, which indicates that cellular and/
or viral processes actively take place and that DHBV is 
presumably entering the cell via endocytosis[33,34]. Studies 
addressing the pH-dependency of  DHBV infection by the 
use of  chemical substances that increase endosomal pH 
led to contradicting results[33,88-90]. However, the weight of  
data favours pH-independent entry as well as an endocytic 
mechanism and shows that the virus does not require 
passage through a highly acidic compartment. The effect 
of  the vATPase inhibitors seem to be due more to effects 
on viral trafficking inside the cell than on the endosomal 
pH alone[34].
After the virus is taken up by the cell via endocytosis, it 
has to be transported to the nucleus to establish infection. 
In the nucleus, the viral rcDNA is converted into the 
cccDNA. This conversion is detectable within the first 
24 h after virus inoculation[27,91]. Thus, after efficient 
viral uptake there is an unusually long gap of  13 to 17 
h before the appearance of  nuclear viral cccDNA. This 
gap suggests that there is a rate-limiting post entry step 
that preceeds cccDNA formation, which involves viral 
uncoating and nuclear genome transport, or is required 
for rc- to cccDNA conversion. The intracellular transport 
has been shown to be independent of  the actin skeleton, 
which in contrast seems to restrict entry, and is strictly 
dependent on the microtubule (MT) network of  the cell[27]. 
Overexpression of  dynamitin, a cofactor subunit of  the 
motor protein complex dynactin-dynein, which mediates 
transport along microtubules, also reduced DHBV 
infection (our unpublished data). To date it remains 
unknown whether the MT-dependent transport of  the 
virus (or the nucleocapsid alone) occurs only at the stage 
of  the endosome or if  the virus alone also interacts with 
microtubules.
To deliver the viral DNA into the nucleus, it has to 
be released from the viral particle and, prior to that, 
the viral particle has to be released from the endosomal 
compartment it resides in. It has been shown that this 
involves an unusual mechanism that depends on the 
integrity of  a so called TLM[32]. The TLM thus mediates 
release of  the viral particle out of  the endosome into 
which it initially entered.
The infectious entry pathway of  hepadnaviruses 
appears to involve a series of  highly coordinated and 
directional steps leading to the nuclear delivery of  viral 
genomes essential for the establishment of  a productive 
infection. These steps may, alone or in combination, 
determine the species and host cell tropism common to all 
hepadnaviruses.
In vivo infection
DHBV-infected ducks exhibit age-related outcomes of  
infection, which is similar to HBV-infected humans. In 
principle, hepadnaviruses have the ability to cause either 
a transient or chronic infection. When infected with 
DHBV, young ducks develop persistent infection whereas 
adult ducks become transiently infected and eliminate 
the virus[92]. These different outcomes are viral dose 
dependent; persistent infection in young ducks develops 
more frequently with higher doses of  virus[92]. In some 
cases, dependent on age and infection with a given mutant, 
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experimental infections can cause symptoms of  a liver 
inflammation[93]. It has been shown that one genome 
equivalent is sufficient to infect a duckling and that spread 
of  the virus within the liver is very efficient: 14 d after 
inoculation, virtually all hepatocytes were infected[94]. In 
addition, it has been shown that the difference between the 
infection outcome in older and neonatal ducks depends 
on the production of  neutralizing antibodies against the 
virus[95]. The rapid production of  neutralizing antibodies in 
older ducks led to an efficient inhibition of  viral spread in 
the liver.
The duck hepatitis B virus infects Chinese domestic 
and American pekin ducks as well as geese. Normally, 
infection takes place through vertical transmission from 
the infected hen to the eggs and results in a chronic 
infection that is without symptoms and is tolerated by the 
immune system[23]. The virus then replicates in the egg 
yolk sack and is transferred to the embryonic hepatocytes 
by day 6 of  development[96]. Thus, all offspring from an 
infected hen are DHBV-positive.
When DHBV infection is persistent in the duck, viral 
replication mainly occurs in the hepatocytes of  the liver. 
Usually, the level of  viral replication is then very high, 
with most hepatocytes infected and expressing the viral 
antigens. This is also reflected in the amount of  viral 
antigens circulating in the blood stream. Up to 1010 virions 
and 1013 SVPs can be detected per ml of  serum[97].
In vivo infections with DHBV are often used to study 
the growth kinetics of  viral mutants[79]. This allows 
elucidation of  specific mutations in the viral genome on 
the behaviour of  this respective mutant in their natural 
host. In contrast to the in vitro situation, the role of  the 
immune system and the spread of  the virus within the 
infected liver can be assessed.
It has been shown that the addition of  lipopolysa-
ccharides (LPS, endotoxin) to PDH cultures inhibited 
DHBV replication efficiently[98]. This was due to the release 
of  interferon alpha and gamma from non-parenchymal 
cells (i.e. Kupffer cells, resident macrophages of  the liver). 
The exact mechanism behind this phenomenon is not 
known.
HOST SPECIFICITY
All known hepadnaviruses are strongly, but not exclusively, 
cell type specific and have a narrow host range restricting 
them to their natural host and a few closely related species 
(Figure 1). DHBV, for example, infects only certain duck 
and goose species, but either does not or very inefficiently 
infects chicken or Muscovy ducks, respectively. Despite 
its substantial sequence homology with DHBV, the heron 
HBV (HHBV) does not infect PDHs. Although ducks 
and duck-derived primary hepatocytes are virtually non-
permissive for HHBV, substitution of  a region of  the 
HHBV-specific preS domain of  the L protein by the 
corresponding sequence from DHBV overcomes this 
species barrier. As a consequence, the pseudotyped HHBV 
virions can efficiently infect primary duck hepatocytes[5]. 
The same is true for mammalian hepadnaviruses, as shown 
for woolly monkey hepatitis B virus pseudotyped with a 
small stretch of  preS1 sequence from HBV, which was 
then infectious for human hepatocytes. Thus, although 
the sequence of  this region is very divergent among the 
different hepadnaviruses, the biological functions seem 
to be conserved. The so called host-determining region 
(HDR) in the preS part of  the avian L protein was mapped 
to amino acids 22 to 90, and an exchange of  this small 
region also changed the species specificity[5]. These studies 
clearly indicate that the block to cross-species infection by 
hepadnaviruses is destined at the level of  infectious viral 
entry. A small domain within the preS region of  the L 
protein plays a pivotal role in host discrimination.
We showed that cranes are naturally infected with a 
novel hepadnavirus, designated crane HBV (CHBV)[14]. 
Phylogenetically, cranes are very distant from ducks and are 
closely related to herons and storks. However, we found 
that CHBV infects PDHs with similar efficiency as DHBV, 
indicating a rather broad host range of  this virus at least 
in vitro. Whether CHBV can establish chronic infection in 
ducks in vivo and is as non-pathogenic as DHBV remains 
to be elucidated. Interestingly, comparison between the 
HDR of  DHBV and the HDR of  CHBV reveals a short 
insert of  3 amino acids (PMP) in the CHBV L protein, a 
sequence similar but not identical to the analogous region 
of  HHBV and STHBV, whereas all other known duck 
and goose hepadnaviruses have no such insert (Figure 7). 
It remains to be shown which sequence features of  the L 
protein are responsible for the unusual broad host range 
of  CHBV and at which level of  infection the block in 
cross-species infection is determined.
Accordingly, comparative genomic and subgenomic 
sequence alignment from different avihepadnaviruses 
facilitates the prediction of  specific properties of  each 
virus and helps to gain insight into the mechanisms 
controlling species specificity and host adaptation.
CHEMOTHERAPY AND VACCINATION
Antiviral drugs currently in use for therapy of  chronic 
hepatitis B are nucleoside analogues and interferon. These 
therapies are unsatisfactory since the virus is usually 
not eliminated from the infected patient and resistant 
viruses frequently appear after treatment with nucleoside 
analogues. These data show the need for additional 
therapies and therapeutic strategies. The therapeutic effect 
of  new vaccination strategies as well as chemotherapeutic 
agents can be assessed with the DHBV model system.
A long- ter m s tudy showed that t rea tment of  
persistently infected ducks with 0.1 mg/kg per day of  
entecavir resulted in a rapid 4-log drop in serum DHBV 
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Figure 7   Sequence comparison of the viral L protein from different 
hepadnaviruses. The first 50 amino acids of the preS domain of hepadnaviral 
L from duck, crane, and heron HBV are shown. The divergent amino acids are 
shown in the lowest lane.
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surface antigen[99]. However, a rapid rebound of  levels 
of  DHBV DNA and antigens in serum and liver was 
observed when entecavir was discontinued. When entecavir 
was administered at the time of  DHBV inoculation, it was 
not effective to prevent infection but it led to a significant 
suppression of  viral spread even after withdrawal of  the 
drug[100]. Thus, short term suppression of  DHBV infection 
shortly after infection provides the opportunity for the 
immune response to successfully control the infection.
Immunotherapy using DNA vaccines has been 
proposed as a way to improve viral clearance via the 
induction of  an effective immune response. It has been 
shown that a DNA vaccine expressing DHBV surface 
antigens induces high levels of  antibodies directed against 
these antigens, which protected or partially protected the 
animals against a challenge with DHBV[101]. This suggests 
that DNA vaccines may be an alternative to conventional 
vaccines for inducing immune response and protection 
against infection.
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